Wells Fargo’s Medtronic MDT Stock Holding History

Wells Fargo’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,800	Closed	-$269K	–	7353
2025 Q4	$269K	Sell	2,800 -43,500	-94%	-$4.23M	﹤0.01%	4900
2025 Q3	$4.41M	Sell	46,300 -11,800	-20%	-$1.08M	﹤0.01%	2689
2025 Q2	$5.06M	Buy	+58,100	New	+$4.93M	﹤0.01%	2460
2025 Q1	–	Sell	-22,200	Closed	-$1.77M	–	7167
2024 Q4	$1.77M	Hold	22,200	–	–	﹤0.01%	3285
2024 Q3	$2M	Buy	+22,200	New	+$1.87M	﹤0.01%	3053
2023 Q4	–	Sell	-22,200	Closed	-$1.74M	–	7671
2023 Q3	$1.74M	Buy	+22,200	New	+$1.86M	﹤0.01%	2914
2020 Q1	–	Sell	-137,200	Closed	-$65K	–	6562
2019 Q4	$65K	Buy	+137,200	New	+$15.1M	﹤0.01%	5434

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wells Fargo's MDT Position: Q2 2026 in Review

Wells Fargo increased its Medtronic (MDT) stake by 5.2% in Q2 2026, buying an estimated $31.5M and bringing the position to 7,904,930 shares worth $618M. The position accounts for 0.1% of the portfolio, ranked #180.

Wells Fargo first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.85B in Q3 2021. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Wells Fargo held 7,904,930 shares of Medtronic worth $618M as of Q2 2026.
Wells Fargo bought 390,152 Medtronic shares in Q2 2026, an estimated $31.5M.
Medtronic made up 0.1% of Wells Fargo's portfolio in Q2 2026, its #180 holding.
Wells Fargo first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
Wells Fargo's Medtronic position peaked at $1.85B in Q3 2021.
2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.